NM_000424.4(KRT5):c.579C>A (p.Asn193Lys)Pathogenic
not provided|Epidermolysis bullosa simplex 1A, generalized severe
β
β
ββ2026β Residue 193
NM_000424.4(KRT5):c.1429G>A (p.Glu477Lys)Pathogenic
Epidermolysis bullosa simplex 1A, generalized severe|not provided|Epidermolysis bullosa simplex 1C, localized|Epidermolysis bullosa simplex with mottled pigmentation|Epidermolysis bullosa simplex|Epidermolysis bullosa simplex 2A, generalized severe|KRT5-related disorder|Epidermolysis bullosa simplex 2B, generalized intermediate
β
β
ββ2026β Residue 477
NM_000424.4(KRT5):c.980T>C (p.Met327Thr)Pathogenic
not provided|7 conditions|Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex 2C, localized|KRT5-related disorder
β
β
ββ2025β Residue 327
NM_000424.4(KRT5):c.482T>G (p.Ile161Ser)Pathogenic
not provided|Epidermolysis bullosa simplex 2C, localized|Epidermolysis bullosa simplex 1C, localized|KRT5-related disorder
β
β
ββ2025β Residue 161
NM_000424.4(KRT5):c.74C>T (p.Pro25Leu)Pathogenic
Epidermolysis bullosa simplex with mottled pigmentation|not provided|Epidermolysis bullosa simplex|KRT5-related disorder|Inborn genetic diseases
β
β
ββ2025β Residue 25
NM_000424.4(KRT5):c.502G>A (p.Glu168Lys)Pathogenic
not provided
β
β
ββ2025β Residue 168
NM_000424.4(KRT5):c.556G>A (p.Val186Met)Pathogenic
not provided|Epidermolysis bullosa simplex
β
β
ββ2025β Residue 186
NM_000424.4(KRT5):c.1649del (p.Gly550fs)Pathogenic
Epidermolysis bullosa simplex with migratory circinate erythema|not provided|Epidermolysis bullosa simplex|Epidermolysis bullosa simplex with mottled pigmentation|KRT5-related disorder
β
β
ββ2025β Residue 550
NM_000424.4(KRT5):c.1388T>C (p.Leu463Pro)Pathogenic
not provided|Epidermolysis bullosa simplex|Epidermolysis bullosa simplex 2B, generalized intermediate
β
β
ββ2024β Residue 463
NM_000424.4(KRT5):c.968T>C (p.Val323Ala)Pathogenic
not provided|Epidermolysis bullosa simplex|Epidermolysis bullosa simplex 2B, generalized intermediate
β
β
ββ2024β Residue 323
NM_000424.4(KRT5):c.991C>T (p.Arg331Cys)Pathogenic
not provided|Epidermolysis bullosa simplex 1C, localized|Dowling-Degos disease 1
β
β
ββ2024β Residue 331
NM_000424.4(KRT5):c.992G>A (p.Arg331His)Pathogenic
not provided|KRT5-related disorder|Epidermolysis bullosa
β
β
ββ2024β Residue 331
NM_000424.4(KRT5):c.1396G>C (p.Glu466Gln)Pathogenic
Epidermolysis bullosa simplex|not provided
β
β
ββ2024β Residue 466
NM_000424.4(KRT5):c.527A>G (p.Asn176Ser)Pathogenic
not provided|Epidermolysis bullosa simplex with mottled pigmentation
β
β
ββ2024β Residue 176
NM_000424.4(KRT5):c.495G>C (p.Arg165Ser)Pathogenic
not provided
β
β
ββ2024β Residue 165
NM_000424.4(KRT5):c.1283C>T (p.Ala428Val)Pathogenic
not provided|Epidermolysis bullosa simplex
β
β
ββ2023β Residue 428
NM_000424.4(KRT5):c.1400T>C (p.Ile467Thr)Pathogenic
not provided
β
β
ββ2023β Residue 467
NM_000424.4(KRT5):c.508G>A (p.Glu170Lys)Pathogenic
not provided|Epidermolysis bullosa simplex|Epidermolysis bullosa simplex 2C, localized|KRT5-related disorder
β
β
ββ2023β Residue 170
NM_000424.4(KRT5):c.1427G>A (p.Gly476Asp)Pathogenic
not provided|Epidermolysis bullosa simplex 1A, generalized severe|Epidermolysis bullosa simplex 2B, generalized intermediate
β
β
ββ2023β Residue 476
NM_000424.4(KRT5):c.1398G>C (p.Glu466Asp)Pathogenic
Epidermolysis bullosa simplex|not provided
β
β
ββ2022β Residue 466